Quest Laboratories (NSE:QUESTLAB) YoY EPS Growth: 23.89% (As of Mar. 2026)


NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
52 GF Score
Price ₹91.20
! 5 Warning Signs
View Full Analysis

What is Quest Laboratories YoY EPS Growth?

Quest Laboratories NSE:QUESTLAB +2.47% 52 YoY EPS Growth is 23.89% as of Mar. 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 52/100. The stock has 5 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Quest Laboratories's YoY EPS Growth for the quarter that ended in Mar. 2026 was 23.89%.

Quest Laboratories's Earnings per Share (Diluted) for the six months ended in Mar. 2026 was ₹4.20.

Quest Laboratories YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Quest Laboratories's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quest Laboratories YoY EPS Growth Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
YoY EPS Growth
Get a 7-Day Free Trial 526.25 1,766.67 -86.83 34.42 10.63

Quest Laboratories Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only 0.00 19.47 44.69 8.77 23.89
NSE:QUESTLAB
52GF Score
Quest Laboratories Ltd NSE:QUESTLAB
YoY EPS Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Quest Laboratories's YoY EPS Growth for the fiscal year that ended in Mar. 2026 is calculated as:

YoY EPS Growth (A: Mar. 2026 )
=(Earnings per Share (Diluted) (A: Mar. 2026 )-Earnings per Share (Diluted) (A: Mar. 2025 ))/ | Earnings per Share (Diluted) (A: Mar. 2025 ) |
=(9.16-8.28)/ | 8.28 |
=10.63 %

Quest Laboratories's YoY EPS Growth for the quarter that ended in Mar. 2026 is calculated as:

YoY EPS Growth (Q: Mar. 2026 )
=(Earnings per Share (Diluted) (Q: Mar. 2026 )-Earnings per Share (Diluted) (Q: Mar. 2025 )) / | Earnings per Share (Diluted) (Q: Mar. 2025 )) |
=(4.2-3.39)/ | 3.39 |
=23.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 23.89% mean?
Quest Laboratories (NSE:QUESTLAB) has a YoY EPS Growth of 23.89% as of Mar. 2026. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Quest Laboratories and its competitors.
Is Quest Laboratories' YoY EPS Growth too high?
Quest Laboratories' current YoY EPS Growth is 23.89%. Overall, Quest Laboratories has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' YoY EPS Growth compare to LLY and JNJ?
Quest Laboratories' YoY EPS Growth of 23.89% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Drug Manufacturers company?
A good YoY EPS Growth depends on the Drug Manufacturers industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Quest Laboratories and its competitors. Quest Laboratories's current YoY EPS Growth is 23.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current YoY EPS Growth of 23.89%. The current YoY EPS Growth is 23.89%. Quest Laboratories' overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current YoY EPS Growth is 23.89% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
52GF Score

Get the complete analysis for NSE:QUESTLAB

YoY EPS Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹91.20
Price